supp.fit
All Docosahexaenoic Acid study protocols

Docosahexaenoic Acid, Vitamin E, Fish Oil and Omega-3 Fatty Acids: study protocols

4 study groups took Docosahexaenoic Acid together with Vitamin E, Fish Oil and Omega-3 Fatty Acids. These are the doses the studies gave. They are not a recommendation.

Docosahexaenoic Acid: what the research found →

Fewer than 5 study groups in one unit match, too few to draw the chart.

Commonly used together

2 of 4 study groups took Docosahexaenoic Acid, Vitamin E, Fish Oil and Omega-3 Fatty Acids with something else, but nothing that 3 or more different studies gave.

4 study groups

Study
The effects of omega-3 fatty acids on neuropsychological functioning and brain morphology in mid-life adults: a randomized clinical trial
2020 · fish oil group · Adults aged 30–54 years with low dietary EPA and DHA intake and no stated diagnosed condition
400 mg10 IU2 g1 g18 weeks134
Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids
2015 · ω-3 PUFA group · People aged 13–25 with ultra-high risk for psychosis
480 mg7.6 mg2 g1.42 g12 weeks40
Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions
2000 · fish oil (FO) · Healthy subjects; age and sex not specified
1.1 g205 mg9 g2.1 g12 weeks—
Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degeneration
2014 · Group 1 (Vitalux plus Omega-3) · Adults with active wet age-related macular degeneration who had previously received anti-VEGF treatment
200 mg400 IU1.05 g1.05 g—10
Docosahexaenoic Acid, Vitamin E, Fish Oil and Omega-3 Fatty Acids: study protocols | supp.fit